Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS

Detalhes bibliográficos
Autor(a) principal: Araújo-Mariz, Carolline
Data de Publicação: 2016
Outros Autores: Lopes, Edmundo Pessoa, Acioli-Santos, Bartolomeu, Maruza, Magda, Montarroyos, Ulisses Ramos, Ximenes, Ricardo Arraes de Alencar, Lacerda, Heloísa Ramos, Miranda-Filho, Demócrito de Barros, Albuquerque, Maria de Fátima Pessoa Militão de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/19342
Resumo: Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.
id CRUZ_79a7f457d7bb276c76f2f7acaaac16fd
oai_identifier_str oai:www.arca.fiocruz.br:icict/19342
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Araújo-Mariz, CarollineLopes, Edmundo PessoaAcioli-Santos, BartolomeuMaruza, MagdaMontarroyos, Ulisses RamosXimenes, Ricardo Arraes de AlencarLacerda, Heloísa RamosMiranda-Filho, Demócrito de BarrosAlbuquerque, Maria de Fátima Pessoa Militão de2017-06-07T18:36:43Z2017-06-07T18:36:43Z2016ARAÚJO-MARIZ, Caroline et al. Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS. Plos One, v. 11, n. 6, p. 1-15, 22 jun. 2016.1932-6203https://www.arca.fiocruz.br/handle/icict/1934210.1371/journal.pone.0157725engTuberculoseHepatotoxicidadeHIVAIDSSíndrome de Imunodeficiência Adquirida / complicaçõesAntituberculosos / efeitos adversosAntituberculosos / uso terapêuticoLesão Hepática Induzida por Substâncias Químicas e Medicamentosas / patologiaTuberculose / complicaçõesTuberculose / quimioterapiaHepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDSinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia. Recife, PE, Brasil.Secretaria de Saúde de Pernambuco. Hospital Correia Picanço. Recife, PE, Brasil.Universidade de Pernambuco. Instituto de Ciências Biológicas. Recife, PE, Brasil.Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil / Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.Hepatotoxicity is frequently reported as an adverse reaction during the treatment of tuberculosis. The aim of this study was to determine the incidence of hepatotoxicity and to identify predictive factors for developing hepatotoxicity after people living with HIV/AIDS (PLWHA) start treatment for tuberculosis. This was a prospective cohort study with PLWHA who were monitored during the first 60 days of tuberculosis treatment in Pernambuco, Brazil. Hepatotoxicity was considered increased levels of aminotransferase, namely those that rose to three times higher than the level before initiating tuberculosis treatment, these levels being associated with symptoms of hepatitis. We conducted a multivariate logistic regression analysis and the magnitude of the associations was expressed by the odds ratio with a confidence interval of 95%. Hepatotoxicity was observed in 53 (30.6%) of the 173 patients who started tuberculosis treatment. The final multivariate logistic regression model demonstrated that the use of fluconazole, malnutrition and the subject being classified as a phenotypically slow acetylator increased the risk of hepatotoxicity significantly. The incidence of hepatotoxicity during treatment for tuberculosis in PLWHA was high. Those classified as phenotypically slow acetylators and as malnourished should be targeted for specific care to reduce the risk of hepatotoxicity during treatment for tuberculosis. The use of fluconazole should be avoided during tuberculosis treatment in PLWHA.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/19342/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINAL27332812 2016 ara-hep.oa.PDF27332812 2016 ara-hep.oa.PDFapplication/pdf721009https://www.arca.fiocruz.br/bitstream/icict/19342/2/27332812%202016%20ara-hep.oa.PDF325c6d1b4407580d9ce662bb8f85efd4MD52TEXT27332812 2016 ara-hep.oa.PDF.txt27332812 2016 ara-hep.oa.PDF.txtExtracted texttext/plain49909https://www.arca.fiocruz.br/bitstream/icict/19342/3/27332812%202016%20ara-hep.oa.PDF.txtf316c533ce4a82b6ab5f97659af8b218MD53icict/193422019-04-02 17:04:31.885oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-04-02T20:04:31Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
title Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
spellingShingle Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
Araújo-Mariz, Carolline
Tuberculose
Hepatotoxicidade
HIV
AIDS
Síndrome de Imunodeficiência Adquirida / complicações
Antituberculosos / efeitos adversos
Antituberculosos / uso terapêutico
Lesão Hepática Induzida por Substâncias Químicas e Medicamentosas / patologia
Tuberculose / complicações
Tuberculose / quimioterapia
title_short Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
title_full Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
title_fullStr Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
title_full_unstemmed Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
title_sort Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
author Araújo-Mariz, Carolline
author_facet Araújo-Mariz, Carolline
Lopes, Edmundo Pessoa
Acioli-Santos, Bartolomeu
Maruza, Magda
Montarroyos, Ulisses Ramos
Ximenes, Ricardo Arraes de Alencar
Lacerda, Heloísa Ramos
Miranda-Filho, Demócrito de Barros
Albuquerque, Maria de Fátima Pessoa Militão de
author_role author
author2 Lopes, Edmundo Pessoa
Acioli-Santos, Bartolomeu
Maruza, Magda
Montarroyos, Ulisses Ramos
Ximenes, Ricardo Arraes de Alencar
Lacerda, Heloísa Ramos
Miranda-Filho, Demócrito de Barros
Albuquerque, Maria de Fátima Pessoa Militão de
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Araújo-Mariz, Carolline
Lopes, Edmundo Pessoa
Acioli-Santos, Bartolomeu
Maruza, Magda
Montarroyos, Ulisses Ramos
Ximenes, Ricardo Arraes de Alencar
Lacerda, Heloísa Ramos
Miranda-Filho, Demócrito de Barros
Albuquerque, Maria de Fátima Pessoa Militão de
dc.subject.other.none.fl_str_mv Tuberculose
Hepatotoxicidade
HIV
AIDS
topic Tuberculose
Hepatotoxicidade
HIV
AIDS
Síndrome de Imunodeficiência Adquirida / complicações
Antituberculosos / efeitos adversos
Antituberculosos / uso terapêutico
Lesão Hepática Induzida por Substâncias Químicas e Medicamentosas / patologia
Tuberculose / complicações
Tuberculose / quimioterapia
dc.subject.decs.none.fl_str_mv Síndrome de Imunodeficiência Adquirida / complicações
Antituberculosos / efeitos adversos
Antituberculosos / uso terapêutico
Lesão Hepática Induzida por Substâncias Químicas e Medicamentosas / patologia
Tuberculose / complicações
Tuberculose / quimioterapia
description Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2017-06-07T18:36:43Z
dc.date.available.fl_str_mv 2017-06-07T18:36:43Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv ARAÚJO-MARIZ, Caroline et al. Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS. Plos One, v. 11, n. 6, p. 1-15, 22 jun. 2016.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/19342
dc.identifier.issn.pt_BR.fl_str_mv 1932-6203
dc.identifier.doi.pt_BR.fl_str_mv 10.1371/journal.pone.0157725
identifier_str_mv ARAÚJO-MARIZ, Caroline et al. Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS. Plos One, v. 11, n. 6, p. 1-15, 22 jun. 2016.
1932-6203
10.1371/journal.pone.0157725
url https://www.arca.fiocruz.br/handle/icict/19342
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/19342/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/19342/2/27332812%202016%20ara-hep.oa.PDF
https://www.arca.fiocruz.br/bitstream/icict/19342/3/27332812%202016%20ara-hep.oa.PDF.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
325c6d1b4407580d9ce662bb8f85efd4
f316c533ce4a82b6ab5f97659af8b218
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009234446516224